Erli Zhang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms
- Hemophilia Treatment and Research
Papers in
-
- Signaling Pathways in Disease 3
- Natural product bioactivities and synthesis 2
-
- Cardiac Valve Diseases and Treatments 6
- Cardiovascular Function and Risk Factors 3
- Co-authors
- Rama Natarajan (4 shared papers)Marpadga A. Reddy (3 shared papers)A. Tulinsky (5 shared papers)Yongjian Wu (12 shared papers)Robert Charles (2 shared papers)Qianyun Guo (3 shared papers)Haiyang Gao (3 shared papers)Siyong Teng (1 shared paper)
- Journals
- Frontiers in Cardiovascular Medicine (3 papers)Circulation Research (2 papers)Biophysical Chemistry (2 papers)PLoS ONE (2 papers)Coronary Artery Disease (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Erli Zhang
29 papers receiving 1.2k citations
Erli Zhang's Hit Papers
Peers
Comparison fields: 5 of 102
- Cancer Research 247
- Hematology 167
- Geriatrics and Gerontology 44
- Genetics 93
- Clinical Biochemistry 56
Countries citing papers authored by Erli Zhang
This map shows the geographic impact of Erli Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erli Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erli Zhang more than expected).
Fields of papers citing papers by Erli Zhang
This network shows the impact of papers produced by Erli Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erli Zhang. The network helps show where Erli Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Erli Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 359 | |
| 2 | 2018 | 105 | |
| 3 | 1997 | 99 | |
| 4 | 2015 | 96 | |
| 5 | 1999 | 77 | |
| 6 | Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease Hit paper breakdown → | 2023 | 66 |
| 7 | 2019 | 59 | |
| 8 | 1999 | 43 | |
| 9 | 2022 | 41 | |
| 10 | 2016 | 39 | |
| 11 | 2020 | 36 | |
| 12 | 2019 | 33 | |
| 13 | 2016 | 29 | |
| 14 | 2012 | 27 | |
| 15 | 2012 | 24 | |
| 16 | 2014 | 19 | |
| 17 | 2013 | 16 | |
| 18 | 2018 | 15 | |
| 19 | 2004 | 14 | |
| 20 | Phasic change and apoptosis regulation of JAK2/STAT3 pathway in a type 2 diabetic rat model. | 2019 | 10 |
About Erli Zhang
Erli Zhang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cancer Research, Surgery and Hematology, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (6 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Signaling Pathways in Disease (3 papers), Cardiovascular Function and Risk Factors (3 papers), Natural product bioactivities and synthesis (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Cancer Research (247 citations), Hematology (167 citations), Geriatrics and Gerontology (44 citations), Genetics (93 citations) and Clinical Biochemistry (56 citations). Erli Zhang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Rama Natarajan, Marpadga A. Reddy, A. Tulinsky, Yongjian Wu, Robert Charles, Qianyun Guo, Haiyang Gao, Siyong Teng, Rui‐Xia Xu and Linda Lanting. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Circulation Research, Biophysical Chemistry, PLoS ONE and Coronary Artery Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.